Challenges in diagnostics and management of a dysgerminoma in a young female
Article Sidebar
Main Article Content
Abstract
Introduction: A rare case of dysgerminoma led to the prolonged and complex diagnostic journey of a young woman.
Methods: The diagnostic process involved various imaging modalities, including ultrasound, FDG-PET/CT scan and MRI, alongside diagnostic laparoscopy. Additionally, methotrexate was administered based on provisional diagnosis to manage the patient’s condition.
Results: Initial investigations suggested pregnancy of unknown location due to inconclusive ultrasound findings. Subsequent imaging with FDG-PET/CT initially appeared normal, but was followed by MRI, which revealed a solid mass on the right ovary. The definitive diagnosis of dysgerminoma was made during a repeat laparoscopy. The patient received oncologic treatment and recovered fully.
Conclusion: This case emphasizes the challenges in diagnosing rare conditions, which may mimic common clinical diseases, as well as the importance of a comprehensive diagnostic approach.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC BY. The paper and it's contents belong to the author, and can be used by others when giving appropriate credit to the authors and the creator (DJOG).
How to Cite
References
1. DGCG. Ovariecancer - Epidemiologi, arvelige faktorer, screening, sygdomsforløb, stadieinddeling og overlevelse2022. https://www.dmcg.dk/Kliniske-retningslinjer/kliniske-retningslinjer-opdelt-paa-dmcg/gynakologiskcancer/ovariecancer/ovariecancer-epidemiologi-arvelige-faktorer-screening-sygdomsforlob-stadieinddeling-og-overlevelse/
2. Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, Colombo N. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv1-iv18.
3. Hyseni N, Llullaku S, Jashari H, Zahiti K, Hyseni F, Kurshumliu F, et al. Advanced ovarian dysgerminoma infiltrating both ovaries and uterus in a 7-year-old girl. Case Rep Oncol Med. 2014;2014:910852.
4. Sato Y, Hayashi T, Yamamoto H, Niina I, Kuroki N, Iwamura T, Onishi J. Late Recurrence in Ovarian Dysgerminoma Presenting as a Primary Retroperitoneal Tumor: A Case Report and Review of the Literature. Case Rep Pathol. 2020;2020:4737606.
5. DGCG. Persisterende trofoblastsygdom. Dansk Multidisciplinære Cancer Gruppe; 2022. p. 12. https://www.dmcg.dk/siteassets/forside/kliniske-retningslinjer/godkendte-kr/dgcg/dgcg_persisterende_trofoblastsygdom_-version-_1.0_admgodk.20092022.pdf
6. (DGCG) DGCG. Visitation, diagnostik og opfølgning af ikke-epithelial ovariecancer. 2020:54. https://www.dmcg.dk/Kliniske-retningslinjer/kliniske-retningslinjer-opdelt-paa-dmcg/gynakologiskcancer/ovariecancer/visitation-diagnostik-og-opfolgning-af-ikke-epitelial-ovariecancer/
7. Zeppernick F, Meinhold-Heerlein I. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Arch Gynecol Obstet. 2014;290(5):839-42.
8. Sessa C, Schneider DT, Planchamp F, Baust K, Braicu EI, Concin N, et al. ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. Lancet Oncol. 2020;21(7):e360-e8.